This effect was reversed by an antagonist of peroxisome proliferator-activated receptor gamma (PPAR©), suggesting that PPARγ stimulation by n-3 LC-PUFAs or their endogenous derivative may lead to possible new strategies targeting both epithelial neoplastic cells and the tumor microenvironment [123]. The gene discussed is PPARG; the disease is neoplasm.